GSK Gets EC and FDA Approval for Endometrial Cancer Biologic, Jemperli May 3, 2021 Auto Bot News 0 Both the European Commission and FDA have granted approval to GlaxoSmithKline’s Jemperli (dostarlimab) for treating endometrial cancer.
